BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0015 (-33.33%)
At close: Oct 12, 2026
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $2.91 million as of October 13, 2026. It is the 46,907th most valuable company in the world and the 6,295th biggest in the United States. Its market cap has decreased by 80.44% in one year.
Market Cap
2.91M
Enterprise Value
5.03M
Revenue
1.77M
Global Rank
Country Rank
#6,295 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 2.91M, a decrease of -94.16%. That is a compound annual growth rate of -66.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 2.91M | -76.51% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharma-Bio Serv | 10.99M |
| PreAxia Health Care Payment Systems | 9.47M |
| DATATRAK International | 9.17M |
| CompuMed | 8.50M |
| Vynleads | 7.51M |
| Resilient Healthcare | 3.31M |
| StrainsforPains | 2.99M |
| Modern Mobility Aids | 1.83M |